1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BE64646C021BE95E852576820033F487
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/thought-leadership-excellence-services?opendocument
18
19opendocument
2035.172.195.49
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25SPCL




Products & Services

Thought Leadership Excellence Services

ID: SMS-2


Features:

180+ Info Graphics

140+ Data Graphics

260+ Metrics

60+ Narratives

50+ Best Practices


Pages: 372


Published: Pre-2014


Delivery Format: Shipped


Price: Price on Request

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • INCLUDED RESEARCH
Pharmaceutical and healthcare organizations seek the support of key opinion leaders (KOLs) to help them in researching, launching, and marketing new drugs. Since the customer options have increased, thought leadership management has gained importance for influencing large customer groups and building sustainable brands. Pharma companies that excel at thought leadership management can gain easy access into the market and attain persistent success.

To provide pharmaceutical executives with the critical information they need for achieving thought leadership management excellence, we have consolidated significant research materials into the Thought Leadership Excellence Services. These services provide a comprehensive view on current trends, best practices, bottle necks and key insights into managing thought leader relationships and optimizing value from
KOL management.

Our research can benefit executives overseeing thought leadership by shortening their learning curve in many of these areas. For more information about
the Thought Leadership Excellence Services, please contact Cameron Tew at 919-767-9246.

Industries Profiled:
Diagnostic; Pharmaceutical; Biotech; Medical Device; Chemical; Health Care; Manufacturing; High Tech; Consumer Products; Media; Service; Technology; Research


Companies Profiled:
Abaxis; Abbott Laboratories; Actelion; Alcon; Alcon Laboratories; Allergan; Allos Therapeutics; Almirall; Altus Biologics; Amgen; Anesiva; ANS; Astellas; Astrazeneca; Axcan Pharma Inc.; Boehringer Ingelheim; Bristol-Myers Squibb; Cardiac Science Corp; CSL Behring; Eli Lilly and Company; Focus Technologies; Genentech; Innovex; Janssen; Medtronic; Bertek; Novartis; Novo Nordisk; Organon.; Schering Plough; Shire; TTY Biopharm; UCB; Vertex; AstraZeneca; Auxilium; Baxter Healthcare; Bayer; Bayer Healthcare; Bayer Schering AG; Becton Dickinson; Biogen Idec; Boston Scientific; Celgene; Covidien; Cubist Pharmaceuticals; Daiichi Pharmaceutical Co.; Daiichi Sankyo; Discovery Chicago; Eisai; Eli Lilly; EMD Serono; Esteve; Ethicon Endo-Surgery Inc.; Genzyme; GlaxoSmithKline; GlaxoSmithKline Merck; Human Genome Sciences; IDS Canada; Impact Communications; Infosys BPO; Innovex Global; Inspire Pharmaceuticals; Invitrogen; Janssen Cilag Pharmaceutical; Johnson & Johnson; Kendle International; King Pharmaceuticals; Ltd.; Lundbeck; Medrad; Merck; Myriad; Nobel Biocare; Noven Therapeuticals; Nupathe; Ocimum Biosolutions; Onyx Pharmaceuticals; Ortho Biotech; Pfizer; Philips Home Healthcare; Promeco SA de CV; Purdue Pharma; RBP Chemical Corporation; Rivermark LLC; Roche; Sanofi-aventis; Savient Pharmaceuticals; Schering-Plough; Skila; Solvay Pharmaceuticals; Spectrum Pharmaceutical; Steris Corporation; Stiefel; Synapse biomedical; Takeda Pharmaceuticals; Talecris; Teva Pharmaceutical Industries Ltd; Theratechnologies; Theravance; Thoratec Corporation; Tibotec; Transoma Medical; Triple S; UCB Pharma; United Therapeutics; URL Pharma; Victory; Vistakon; Vital Therapies

Who Can Benefit From These Services?

These services contain valuable material regarding thought leadership in the context of patient advocacy while creating effective relationships and global product launches. This is a virtual how-to guide of preparing the market for product launch by utilizing professional and advisory relationships while managing global thought leaders as well as payer influencers. Pharmaceutical executives can use this benchmarking research to learn best practices in Thought Leader management and discover how they can maximize KOL relationships to benefit their own products and therapies.

These services are geared for pharmaceutical executives with responsibilities in the areas of:

Patient advocacy
Resource/budget management
Market research
Medical Science Liaison relations
Key Opinion Leader relations
Key Opinion Leader management





This bundle combines all of the individual research listed below into one easy-to-purchase transaction. Read individual research abstracts by clicking the titles. Return to this page to add the bundle to your cart.